You are here

Article info

Article menu

Download PDFPDF

Neurology
Protocol
Fingolimod and risk of skin cancer among individuals with multiple sclerosis: a population-based cohort study protocol

Authors

  • Analisa Jia Collaboration for Outcomes Research and Evaluation (CORE), Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, British Columbia, Canada International Collaboration on Repair Discoveries (ICORD), The University of British Columbia, Vancouver, British Columbia, Canada PubMed articlesGoogle scholar articles
  • Lisa Kuramoto Centre for Clinical Epidemiology and Evaluation, Vancouver Coastal Health Research Institute, The University of British Columbia, Vancouver, British Columbia, Canada PubMed articlesGoogle scholar articles
  • Amir Khakban Collaboration for Outcomes Research and Evaluation (CORE), Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, British Columbia, Canada PubMed articlesGoogle scholar articles
  • Weng Sut Sio Collaboration for Outcomes Research and Evaluation (CORE), Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, British Columbia, Canada PubMed articlesGoogle scholar articles
  • Anthony Traboulsee Division of Neurology, Department of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada PubMed articlesGoogle scholar articles
  • M A De Vera Collaboration for Outcomes Research and Evaluation (CORE), Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, British Columbia, Canada Centre for Advancing Health, Providence Health Research Institute, Vancouver, British Columbia, Canada PubMed articlesGoogle scholar articles
  • Jiwon Oh Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  • Jonathan Loree Division of Medical Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada PubMed articlesGoogle scholar articles
  • Roger Tam School of Biomedical Engineering, Department of Radiology, The University of British Columbia, Vancouver, British Columbia, Canada PubMed articlesGoogle scholar articles
  • Larry D Lynd Collaboration for Outcomes Research and Evaluation (CORE), Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, British Columbia, Canada Centre for Advancing Health, Providence Health Research Institute, Vancouver, British Columbia, Canada PubMed articlesGoogle scholar articles
  • Jacquelyn J Cragg Collaboration for Outcomes Research and Evaluation (CORE), Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, British Columbia, Canada International Collaboration on Repair Discoveries (ICORD), The University of British Columbia, Vancouver, British Columbia, Canada PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Jacquelyn J Cragg; jacquelyn.cragg{at}icord.org
View Full Text

Citation

Jia A, Kuramoto L, Khakban A, et al
Fingolimod and risk of skin cancer among individuals with multiple sclerosis: a population-based cohort study protocol
BMJ Open 2025;15:e088924. doi: 10.1136/bmjopen-2024-088924

Publication history

  • Received May 17, 2024
  • Accepted December 16, 2024
  • First published January 23, 2025.
Online issue publication 
January 23, 2025

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.